OraSure Technologies Inc - OSUR Net earnings per share for the last four quarters

OraSure Technologies, Inc. (OSUR) - corporate logo

This chart illustrates the market value of OraSure Technologies (OSUR), which reports earnings per share of 14.80, reflecting the performance of its disease diagnostics business. OraSure Technologies relies on the synergy between scientists and engineers to develop rapid tests. Management successfully diversified revenue streams post-pandemic by implementing molecular systems. Patent protection, FDA certification, and close ties with the public healthcare sector ensure the stability of its market position.

OSUR OraSure Technologies Inc: Earnings per share for the last twelve months in the range 02/11/2024 - 11/16/2026

OraSure Corp - analytical breakdowns and key metrics (OSUR)

- market price and analyst price targets:
Initial company analysis:OSUR (OraSure Technologies Inc)
Product sample of OraSure Technologies Inc

Year-over-year (YoY) EPS growth (TTM) measures the change in net income per share over a rolling year, neutralizing seasonal reporting fluctuations. Investors utilize this metric to evaluate profit generation efficiency and identify trend reversal points. Analyzing the percentage dynamics of EPS YoY TTM reveals revenue stagnation for OraSure Technologies (OSUR). This is a result of declining pricing power and competition from low-cost rapid test alternatives.

Direct competitors

A - Net earnings per share (EPS TTM)|Quest Corp (DGX) - Earnings per share for the last twelve months|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months exactsciences.com|revvity.com (RVTY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BIO|Net earnings per share (EPS TTM) Anbio Biotechnology Ltd (NNNN)|Sotera Health - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) QuidelOrtho Corp QDEL|OPK - Earnings per share for the last twelve months|Earnings per share for the trailing year CDNA (caredx.com)|MRVI: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Fulgent Genetics FLGT|LAB (Standard BioTools Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Cytek Biosciences, Inc.|Net earnings per share for the last 12 months XGN (Exagen Inc)|Net earnings per share (EPS TTM) mdxhealth.com (MDXH)|Net earnings per share (EPS TTM) LUCD (Lucid Diagnostics Inc)|PRE - Net earnings per share for the last 12 months|IMDX: Net earnings per share for the last 12 months|Earnings per share for the trailing year TRIB (trinitybiotech.com)|PRPH (ProPhase Labs, Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Ainos|Earnings per share for the last twelve months Co-Diagnostics Inc|HSCS (Heart Test Laboratories Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) BMRA|Cardio Diagnostics Holdings Inc. (CDIO) - Net earnings per share for the trailing year|Earnings per share for the last twelve months Onconetix ONCO|viraxbiolabs.com - Earnings per share for the last twelve months|BJDX - Earnings per share for the last twelve months|Earnings per share for the trailing year AWH (Aspira Women's Health Inc.)|AXDX: Net earnings per share (EPS TTM)|CNTG - Net earnings per share for the last four quarters|ENZ (enzo.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months FRES|Earnings per share for the last twelve months Genetic Technologies (GENE)|Net earnings per share for the last four quarters 23andMe Holding Co|Net earnings per share (EPS TTM) PMD (Psychemedics)